105 related articles for article (PubMed ID: 2070447)
1. Design, synthesis and antiinflammatory activity of a new indomethacin ester. 2-[N-[3-(3-(piperidinomethyl)phenoxy)propyl]carbamoylmethylthio]ethyl 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetate.
Ueda I; Ishii K; Arai H; Ikeda S; Hitomi Y; Hatanaka M
Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):679-84. PubMed ID: 2070447
[TBL] [Abstract][Full Text] [Related]
2. Glycerides as prodrugs. 3. Synthesis and antiinflammatory activity of [1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetyl]glycerides (indomethacin glycerides).
Paris GY; Garmaise DL; Cimon DG; Swett L; Carter GW; Young P
J Med Chem; 1980 Jan; 23(1):9-13. PubMed ID: 7359519
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory, analgesic, and antipyretic effects and gastrointestinal toxicity of the new anti-inflammatory drug N-(3-[3-(piperidinylmethyl)phenoxy]propyl)-carbamoylmethylthio ]ethyl 1-(p-chlorobenzoyl) 5-methoxy-2-methyl-3-indolylacetate.
Segawa Y; Ohya O; Abe T; Omata T; Tsuzuike N; Itokazu Y; Yoshida K; Tagashira E; Ueda I
Arzneimittelforschung; 1992 Jul; 42(7):954-8. PubMed ID: 1418061
[TBL] [Abstract][Full Text] [Related]
4. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.
Huang Z; Velázquez CA; Abdellatif KR; Chowdhury MA; Reisz JA; DuMond JF; King SB; Knaus EE
J Med Chem; 2011 Mar; 54(5):1356-64. PubMed ID: 21280601
[TBL] [Abstract][Full Text] [Related]
5. Effect of a new non-steroidal anti-inflammatory combination of a histamine H2 antagonist and indomethacin on gastroduodenal mucosal membrane in rat.
Segawa Y; Omata T; Abe T; Tsuzuike N; Itokazu Y; Yoshida K; Ueda I
Arzneimittelforschung; 1992 Oct; 42(10):1232-5. PubMed ID: 1361736
[TBL] [Abstract][Full Text] [Related]
6. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of orally active prodrugs of indomethacin.
Bandgar BP; Sarangdhar RJ; Viswakarma S; Ahamed FA
J Med Chem; 2011 Mar; 54(5):1191-201. PubMed ID: 21284386
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profiles of 2-carboxyphenyl-1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate and 2-[(2-carboxyphenoxy)-carbonyl]phenyl-1-(4-chlorobenzoyl)-5-meth oxy-2- methylindole-3-acetate, new antiinflammatory agents.
Tanaka I; Yoshizumi H; Tanaka Y; Takeda S; Kamei C; Nakaya N; Kitazumi K; Tagami H; Tasaka K
Arzneimittelforschung; 1986 Apr; 36(4):703-9. PubMed ID: 3487327
[TBL] [Abstract][Full Text] [Related]
9. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and ulcerogenic effects of 3-(N,N-diethylamino) propylindometacin HCl.
Huang ZL; Kagoshima M; Kagawa E; Wang WQ; Shimada H
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):306-8. PubMed ID: 10072910
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of oligoethylene ester derivatives as indomethacin oral prodrugs.
De Caprariis P; Palagiano F; Bonina F; Montenegro L; D'Amico M; Rossi F
J Pharm Sci; 1994 Nov; 83(11):1578-81. PubMed ID: 7891278
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of indomethacin farnesil, a novel antiinflammatory prodrug, on carrageenin-induced inflammation in rats.
Kumakura S; Mishima M; Kobayashi S; Shirota H; Abe S; Yamada K; Tsurufuji S
Agents Actions; 1990 Mar; 29(3-4):286-91. PubMed ID: 2339670
[TBL] [Abstract][Full Text] [Related]
13. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen.
Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K
Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616
[TBL] [Abstract][Full Text] [Related]
14. Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez CA; Chen QH; Citro ML; Keefer LK; Knaus EE
J Med Chem; 2008 Mar; 51(6):1954-61. PubMed ID: 18314945
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of an anti-inflammatory-histamine H2 antagonist drug complex on gastric erosions in the rat.
Imai T; Fukuhara A; Ueda I; Otagiri M
J Pharmacol Exp Ther; 1993 Apr; 265(1):328-33. PubMed ID: 8097246
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and stability of two indomethacin prodrugs.
Chandrasekaran S; Al-Ghananeem AM; Riggs RM; Crooks PA
Bioorg Med Chem Lett; 2006 Apr; 16(7):1874-9. PubMed ID: 16439128
[TBL] [Abstract][Full Text] [Related]
17. Prodrugs. Part 3. 2-Formylphenyl esters of indomethacin, ketoprofen and ibuprofen and 6-substituted 2-formyl and 2-acylphenyl esters of aspirin.
Abordo EA; Bowden K; Huntington AP; Powell SL
Farmaco; 1998 Feb; 53(2):95-101. PubMed ID: 9604316
[TBL] [Abstract][Full Text] [Related]
18. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
19. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic and pharmacodynamic profile of the trioxyethylene ester of indomethacin in a new oral prodrug].
Palagiano F; de Caprariis P; Bonina FP; Montenegro L; Capasso A; Sorrentino L
Boll Chim Farm; 1996 Feb; 135(2):89-91. PubMed ID: 9044565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
